ESC 365 - Clinical risk prediction for left atrial appendage thrombus among patients with atrial fibrillation

ESC Professional Premium Access

Clinical risk prediction for left atrial appendage thrombus among patients with atrial fibrillation

Session: Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

Topic: Rhythm Control, Cardioversion

Speaker: Doctor P. Kistler (Melbourne, AU)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Peter Kistler

The Alfred Hospital, Melbourne (Australia)

4 presentations

1 follower

4 more presentations in this session

Risk of stroke and transient ischemic attack after elective cardioversion of atrial fibrillation: A nationwide study in Finland

Speaker: Mrs S. Itainen-Stromberg (Helsinki, FI)

Left atrial appendage occlusion versus standard of care in patients with atrial fibrillation and a prior thrombo-embolic event despite oral anticoagulant therapy: a propensity score matched comparison

Speaker: Professor L. Boersma (Nieuwegein, NL)

Decreased device related thrombus and enhanced neo-endocardial tissue maturation with a new generation left atrial appendage closure (LAAC) device. An anticoagulation and antiplatelet free canin study

Speaker: Professor W. Saliba (Cleveland, US)

Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry

Speaker: Doctor W. Ding (Liverpool, GB)

Access the full session

Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

Speakers: Doctor P. Kistler, Mrs S. Itainen-Stromberg, Professor L. Boersma, Professor W. Saliba, Doctor W. Ding

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources